Blueshift Asset Management, LLC Pacific Biosciences Of California, Inc. Transaction History

Blueshift Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$24.86 - $35.02 $679,125 - $956,676	-27,318 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$22.3 - $36.02 $609,191 - $983,994	27,318 New	27,318 $955,000
Q1 2020 May 14, 2020	SELL	$2.36 - $5.26 $34,116 - $76,038	-14,456 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.6 - $5.57 $66,497 - $80,519	14,456 New	14,456 $74,000
Q3 2019 Nov 12, 2019	SELL	$4.99 - $6.16 $70,843 - $87,453	-14,197 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$5.92 - $7.41 $12,171 - $15,234	-2,056 Reduced 12.65%	14,197 $86,000
Q1 2019 May 14, 2019	BUY	$6.8 - $7.4 $110,520 - $120,272	16,253 New	16,253 $118,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.